CLINUVEL PHARMACEUTICALS LTD

Call Directions Website

CLINUVEL PHARMACEUTICALS LTD Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from CLINUVEL PHARMACEUTICALS LTD, Medical and health, 535 Bourke Street, Melbourne.

CLINUVEL is a global specialty pharmaceutical group focused on developing and commercialising treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialised populations.

23/09/2026

It’s not every day our work ends up several stories tall in Times Square. Five new animations are running on the Nasdaq billboard this week, each one with its own personality. It also comes at a moment when we’ve been speaking more openly about what a larger presence in the U.S.A. could mean for CLINUVEL.

If you’re anywhere near Times Square this week, look up — good odds you’ll catch one.

After developing vitiligo at eight years old, Phelix Owiny began a long journey to self-acceptance.Read his story on the...
18/09/2026

After developing vitiligo at eight years old, Phelix Owiny began a long journey to self-acceptance.

Read his story on the Vitiligo Hub here: https://bit.ly/4hjwYbv

01/09/2026

Being first isn’t always the advantage.

CLINUVEL CEO Philippe Wolgen explains how Incyte’s JAK inhibitor — repositioned for vitiligo — helped bring the disease onto the radar of the FDA and insurers, opening the door for other therapies, including CLINUVEL’s, to be recognised.

His takeaway: sometimes it pays to be the second mover, not the first.

🎥 Full interview — https://news.clinuvel.com/risk-cash-and-a-hostile-takeover-clinuvel-considers-nasdaq-20280901/

For years, vitiligo was written off as “just cosmetic”. That sentiment is changing: we now understand vitiligo as a real...
05/08/2026

For years, vitiligo was written off as “just cosmetic”. That sentiment is changing: we now understand vitiligo as a real disease, and it is finally getting the attention it deserves.

The progress is worth celebrating, but we must not lose sight of the science beneath it: the treatments getting the most attention work by quieting the immune attack. That can help, but it’s often not the whole answer, and the results don’t always last.

We laid out the full picture on our Vitiligo Hub: https://www.clinuvel.com/2026/07/only-part-of-the-story-why-we-likely-need-more-than-immune-suppression-to-treat-vitiligo/

CLINUVEL shared a commercial update on the emerging vitiligo market with current standard of care of narrowband ultravio...
30/07/2026

CLINUVEL shared a commercial update on the emerging vitiligo market with current standard of care of narrowband ultraviolet B (NB-UVB) phototherapy, and Janus kinase (JAK) inhibitors under development for vitiligo. With the completion of the Company’s advanced trial CUV105 comparing SCENESSE® (afamelanotide) and the adjunct NB-UVB therapy to the monotherapy NB-UVB, this commercial review addresses recently posed questions while providing objective peer reviewed benchmarks.

Read it here: https://www.clinuvel.com/2026/07/commercial-update-on-vitiligo-20260730/

Address

535 Bourke Street
Melbourne, VIC
3000

Telephone

+61396604900

Website

Alerts

Be the first to know and let us send you an email when CLINUVEL PHARMACEUTICALS LTD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category